ConductScience.org, home

Paper8242539

Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.

Wooten MD and 1 other. Cancer, 1993. Cited by 266 papers, by iCite.

Cite this record

ConductScience Library. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Papers, record 8242539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8242539

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.
PubMed
Journal
Cancer
PubMed
Year
1993
PubMed
Publication types
Journal Article, Meta-Analysis
PubMed
Citations, by iCite
266
iCite
Relative citation ratio, by iCite
8.76
iCite
Revised in PubMed
2022-03-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wooten MDM D
2King DKD K

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenal Cortex NeoplasmsMajor topic
Adrenocortical CarcinomaMajor topic
MitotaneMajor topic
Adolescent
Adrenal Cortex
Adult
Age Factors
Aged
Female
Humans
Male
Middle Aged
Neoplasm Staging
Remission Induction
Retrospective Studies
Sex Factors
Survival Rate

Source PubMed

Download CSV of topics

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 266 citations.

PMIDTitleJournalYearIn PapersSource
42137725Pseudo-Progression Observed During Immune Checkpoint Inhibitor Therapy for Advanced Adrenocortical Carcinoma.IJU Case Rep2026https://conductscience.org/library/papers/42137725PubMed
40206460Geographical Variation in Adrenocortical Carcinoma Incidence Across Colorado.J Endocr Soc2025https://conductscience.org/library/papers/40206460PubMed
40014786Management of adrenocortical carcinoma in Slovenia: a real-life analysis of histopathologic markers, treatment patterns, prognostic factors, and survival.Radiol Oncol2025https://conductscience.org/library/papers/40014786PubMed
39263332Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery.Cancer Manag Res2024https://conductscience.org/library/papers/39263332PubMed
39071458Circadian rhythm disruption and endocrine-related tumors.World J Clin Oncol2024https://conductscience.org/library/papers/39071458PubMed
38463201Surgical Management of Metastatic Adrenocortical Carcinoma.World J Surg2024https://conductscience.org/library/papers/38463201PubMed
37925657Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma.Ann Surg Oncol2024https://conductscience.org/library/papers/37925657PubMed
37829670Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.EJC Paediatr Oncol2023https://conductscience.org/library/papers/37829670PubMed
37297933Review of Diagnostic Modalities for Adrenal Incidentaloma.J Clin Med2023https://conductscience.org/library/papers/37297933PubMed
37185426A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.Curr Oncol2023https://conductscience.org/library/papers/37185426PubMed
36151566Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/36151566PubMed
35983531Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma.Comput Math Methods Med2022https://conductscience.org/library/papers/35983531PubMed
35865995Adrenal Mass in a 70-Year-Old Woman.Case Rep Endocrinol2022https://conductscience.org/library/papers/35865995PubMed
35782795Adrenocortical Carcinoma: a Therapeutic Challenge - 44 Cases from a Single Tertiary Care Center in India.Indian J Surg Oncol2022https://conductscience.org/library/papers/35782795PubMed
35681785Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels.Cancers (Basel)2022https://conductscience.org/library/papers/35681785PubMed
35580936Iliac vein deep vein thrombosis as an atypical presentation of an adrenocortical carcinoma.BMJ Case Rep2022https://conductscience.org/library/papers/35580936PubMed
34850915Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival.J Clin Endocrinol Metab2022https://conductscience.org/library/papers/34850915PubMed
34559356Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?Endocrine2021https://conductscience.org/library/papers/34559356PubMed
34349894Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.Ther Adv Chronic Dis2021https://conductscience.org/library/papers/34349894PubMed
34148966Adrenocortical Carcinoma Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration.Intern Med2021https://conductscience.org/library/papers/34148966PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8242539

GET https://conductscience.org/api/papers/v1/8242539/cited_by?page=2